US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug - Reuters
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNV2FXR19tUWxiQ2RMdWp5SHJZUFlpSEUtamdIMXdReTd4UzV0Zm0xODZCeGE0bEt4Nmd2MVV6akl6OGtQdVVwNTlEczIwcHVhVGNHVVplMUROQUZoUTFKcHI1ajY1Y3UydGZsZGtsM3duc3BDeDlWQl9LaGtaNFgtMk1LbWcwTXlkVEpIOEMtTGppOTFJMVBPX3RnS0xOaFR1ekhyWlhHMTlLYWplclF4LTFvd3NFWC02V2NrOE9VQzNtX0R0RmJz?oc=5" target="_blank">US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug</a> <font color="#6f6f6f">Reuters</font>
U.S. cancer centers are urgently enrolling patients in an early access program for Revolution Medicines' experimental drug daraxonrasib, following its FDA-approved expanded access program on May 1, 2026.
Medscape reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, highlighting the FDA's recent approval for expanded access.
Medscape discusses the urgency among U.S. cancer clinics to provide patients with access to Revolution Medicines' experimental drug daraxonrasib, following the FDA's approval for expanded access.
Medscape reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, following the FDA's recent approval for expanded access.
Medscape discusses the urgency among U.S. cancer clinics to provide patients with access to Revolution Medicines' experimental drug daraxonrasib, following the FDA's approval for expanded access.
Yahoo News Malaysia reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, following the FDA's recent approval for expanded access.
Similar Stories
Related coverage based on topic and tags
GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters
July 13, 2026 at 06:45 PMGSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters
July 10, 2026 at 01:46 PMUS FDA approves Sanofi's wearable injector form of blood cancer drug - Reuters
US FDA approves Sanofi's wearable injector form of blood cancer drug Reuters
July 10, 2026 at 05:49 PMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PMUS FDA approves Vera's kidney disease drug - Reuters
US FDA approves Vera's kidney disease drug Reuters
July 7, 2026 at 05:09 PMWarburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports - Reuters
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports Reuters
July 10, 2026 at 05:35 PM